KRAS and familial pancreatic carcinoma: Similar proportions of KRAS mutations at codons 61 and 13 were observed in cfDNA of pancreatic cancer cases (7.2% and 3.1% respectively) as compared to PDAC ICGC tumors (6.1% and 1.7% respectively).